Office of Research on Women's Health; Notice of Meeting; Moving Into the Future-New Dimensions and Strategies for Women's Health Research for the National Institutes of Health, 6647-6648 [E9-2760]

Download as PDF Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel, Cell Biology SBIR/STTR. Date: March 13, 2009. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Alexandra M. Ainsztein, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5144, MSC 7840, Bethesda, MD 20892, 301–451– 3848, ainsztea@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 2, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2600 Filed 2–9–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Research on Women’s Health; Notice of Meeting; Moving Into the Future—New Dimensions and Strategies for Women’s Health Research for the National Institutes of Health erowe on PROD1PC63 with NOTICES Notice is hereby given that the Office of Research on Women’s Health (ORWH), Office of the Director, National Institutes of Health, Department of Health and Human Services, in collaboration with the Center for Women’s Infectious Disease Research, Washington University School of Medicine, will convene a public hearing and scientific workshop on March 4–6, 2009, at Washington University, Edward P. Newman Education Center, St. Louis, Missouri. Purpose of the Meeting With rapid advances in science and wider global understanding of women’s health and sex/gender contributions to well-being and disease, the purpose of the meeting is to ensure that NIH continues to support cutting edge women’s health research that is based upon the most advanced techniques and methodologies. The conference format will promote an interactive discussion involving leading scientists, advocacy groups, public policy experts, health care providers, and the general public. The St. Louis conference is the first in a series that will be convened VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 throughout the Nation to assist the ORWH and the NIH to move into the next decade of women’s health research. As science and technology advance and fields such as computational biology demonstrate the power of interdisciplinary research, it remains critical for sex and gender factors to be integrated into broad experimental methodologies and scientific approaches, such as genomics and the Human Microbiome Project, to maximize the value of these comprehensive and powerful approaches. Biomedical and behavioral research are also necessary to understand how cultural, ethnic, and racial differences influence the cause, diagnosis, progression, treatment, and outcome of disease among different populations, including women of diverse geographic locations and socioeconomic backgrounds. Furthermore, health disparities among diverse populations of women remain a critical area in need of continued focus and attention. The ORWH challenges all conference attendees to assist it and the NIH in defining the women’s health research agenda of the future and to think beyond traditional women’s health issues. The attendees need to identify creative strategies that are best poised for advancement, address innovative ways to approach persistent issues of health and disease, and explore new scientific concepts and investigative approaches. The attendees need to pay attention to new areas of science application, new technologies, or continuing basic science investigations. The attendees should also consider clinical questions that are not currently the focus of research priorities to ensure that women’s health research is optimally served and that the ORWH can continue to provide leadership for the benefit of women’s health, nationally and internationally. Conference Format The Conference will consist of public testimony followed by scientific panels and six concurrent workshops. Specifically, on March 4, individuals representing the full spectrum of organizations interested in biomedical and behavioral research on women’s health issues will have an opportunity to provide public testimony from 2–6 p.m. On March 5, the intersection of health care, public policy, and biomedical research will be addressed in a keynote speech designed to stimulate discussion by subsequent panels. The panels will focus on emerging issues and trends in health care that will be facing the Nation and PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 6647 on research paradigms of the future. The six concurrent afternoon sessions will focus on a range of research areas, including metagenomics/microbiome, chronic pain, urogenital disorders, the brain and neuropsychiatric disorders, urogenital infection, and obesity and eating disorders. On March 6, the morning session will be devoted to reports from the workshop co-chairs on the deliberations of the workshops. Throughout the sessions, conference attendees will be encouraged to assist the ORWH and NIH in shaping the future of women’s health research and, by extension, informing health care policy. The conference will adjourn at 1 p.m. on March 6. Public Testimony The ORWH invites individuals representing organizations with an interest in research areas related to women’s health to provide written and oral testimony on these topics and/or on issues related to women in biomedical careers. Due to time constraints, only one representative from an organization or professional specialty group will present oral testimony, with presentations limited to 5–7 minutes. Similarly, individuals not representing an organized entity but a personal point of view will have the same time constraint. A letter of intent to present such testimony should be sent electronically to https:// www.orwhmeetings.com/newdirections/ or by mail to Ms. Jory Barone, Educational Services, Inc., 4350 EastWest Highway, Suite 1100, Bethesda, MD 20814, joryb@esi-dc.com. The date of receipt of the communication will establish the order of presentations at the March meeting. Testimony should include a brief description of the organization; is limited to no more than 10 pages, double spaced, 12 point font size; and should be forwarded to the Web site listed above no later than February 20, 2009. Individuals and organizations wishing to provide written statements only should send two (2) copies of their statements, electronically or by mail, to the above Web site or address by February 20, 2009. All written testimony will be made available to the conferees prior to the March 4 meeting date. Logistics questions related to the March conference should be addressed to Ms. Jory Barone at ESI, while program-specific questions should be addressed to Dr. Jennifer Stine Elam at Washington University, 314–747–0729, elam@wustl.edu. This conference is the first of four regional public hearings and scientific E:\FR\FM\10FEN1.SGM 10FEN1 6648 Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices workshops of similar design to be convened by the ORWH. At the conclusion of the regional conferences, the ORWH will hold a meeting at the NIH to develop a summation of the deliberations from the regional conferences. The resulting report to the ORWH and the NIH will ensure that women’s health research will incorporate vigorous new ideas and approaches in the next decade. Dated: February 3, 2009. Raynard S. Kington, Acting Director, National Institutes of Health. [FR Doc. E9–2760 Filed 2–9–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center on Minority Health and Health Disparities; Notice of Meeting erowe on PROD1PC63 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council on Minority Health and Health Disparities. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Minority Health and Health Disparities. Date: February 24, 2009. Closed: 8 a.m. to 9:30 a.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Open: 9:30 a.m. to 5 p.m. Agenda: The agenda will include opening remarks, administrative matters, Director’s Report, NCMHD Health Disparities update, VerDate Nov<24>2008 14:17 Feb 09, 2009 Jkt 217001 Scientific Programs Highlight, and other business of the Council. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Donna Brooks, Asst. Director for Administration, National Center on Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, 301–435–2135, brooksd@ncmhd.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Dated: February 2, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2598 Filed 2–9–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2008–1036] Collection of Information Under Review by Office of Management and Budget: OMB Control Numbers: 1625– 0079 and 1625–0088 Coast Guard, DHS. Thirty-day notice requesting comments. AGENCY: ACTION: SUMMARY: In compliance with the Paperwork Reduction Act of 1995, this request for comments announces that the U.S. Coast Guard is forwarding two Information Collection Requests (ICRs), abstracted below, to the Office of Information and Regulatory Affairs (OIRA), Office of Management and Budget (OMB) requesting an extension PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 of its approval for the following collections of information: 1625–0079, Standards of Training, Certification and Watchkeeping for Seafarers (STCW), 1995 and 1997 Amendments to the International Convention; and 1625– 0088, Voyage Planning for Tank Barge Transits in the Northeast United States. Our ICRs describe the information we seek to collect from the public. Review and comments by OIRA ensure we only impose paperwork burdens commensurate with our performance of duties. DATES: Please submit comments on or before March 12, 2009. ADDRESSES: You may submit comments identified by Coast Guard docket number [USCG–2008–1036] to the Docket Management Facility (DMF) at the U.S. Department of Transportation (DOT) or to OIRA. To avoid duplication, please submit your comments by only one of the following means: (1) Electronic submission. (a) To Coast Guard docket at https:// www.regulation.gov. (b) To OIRA by email via: oira_submission@omb.eop.gov. (2) Mail or Hand delivery. (a) DMF (M–30), DOT, West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue, SE., Washington, DC 20590– 0001. Hand deliver between the hours of 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The telephone number is 202–366–9329. (b) To OIRA, 725 17th Street, NW., Washington, DC 20503, to the attention of the Desk Officer for the Coast Guard. (3) Fax. (a) To DMF, 202–493–2251. (b) To OIRA at 202–395–6566. To ensure your comments are received in time, mark the fax to the attention of the Desk Officer for the Coast Guard. The DMF maintains the public docket for this Notice. Comments and material received from the public, as well as documents mentioned in this Notice as being available in the docket, will become part of the docket and will be available for inspection or copying at room W12–140 on the West Building Ground Floor, 1200 New Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. You may also find the docket on the Internet at https://www.regulations.gov. Copies of the ICRs are available through the docket on the Internet at https://www.regulations.gov. Additionally, copies are available from Commandant (CG–611), U.S. Coast Guard Headquarters, (Attn: Mr. Arthur Requina), 2100 2nd Street, SW., Washington, DC 20593–0001. The telephone number is 202–475–3523. E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 74, Number 26 (Tuesday, February 10, 2009)]
[Notices]
[Pages 6647-6648]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2760]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Research on Women's Health; Notice of Meeting; Moving 
Into the Future--New Dimensions and Strategies for Women's Health 
Research for the National Institutes of Health

    Notice is hereby given that the Office of Research on Women's 
Health (ORWH), Office of the Director, National Institutes of Health, 
Department of Health and Human Services, in collaboration with the 
Center for Women's Infectious Disease Research, Washington University 
School of Medicine, will convene a public hearing and scientific 
workshop on March 4-6, 2009, at Washington University, Edward P. Newman 
Education Center, St. Louis, Missouri.

Purpose of the Meeting

    With rapid advances in science and wider global understanding of 
women's health and sex/gender contributions to well-being and disease, 
the purpose of the meeting is to ensure that NIH continues to support 
cutting edge women's health research that is based upon the most 
advanced techniques and methodologies. The conference format will 
promote an interactive discussion involving leading scientists, 
advocacy groups, public policy experts, health care providers, and the 
general public. The St. Louis conference is the first in a series that 
will be convened throughout the Nation to assist the ORWH and the NIH 
to move into the next decade of women's health research.
    As science and technology advance and fields such as computational 
biology demonstrate the power of interdisciplinary research, it remains 
critical for sex and gender factors to be integrated into broad 
experimental methodologies and scientific approaches, such as genomics 
and the Human Microbiome Project, to maximize the value of these 
comprehensive and powerful approaches. Biomedical and behavioral 
research are also necessary to understand how cultural, ethnic, and 
racial differences influence the cause, diagnosis, progression, 
treatment, and outcome of disease among different populations, 
including women of diverse geographic locations and socioeconomic 
backgrounds. Furthermore, health disparities among diverse populations 
of women remain a critical area in need of continued focus and 
attention.
    The ORWH challenges all conference attendees to assist it and the 
NIH in defining the women's health research agenda of the future and to 
think beyond traditional women's health issues. The attendees need to 
identify creative strategies that are best poised for advancement, 
address innovative ways to approach persistent issues of health and 
disease, and explore new scientific concepts and investigative 
approaches. The attendees need to pay attention to new areas of science 
application, new technologies, or continuing basic science 
investigations. The attendees should also consider clinical questions 
that are not currently the focus of research priorities to ensure that 
women's health research is optimally served and that the ORWH can 
continue to provide leadership for the benefit of women's health, 
nationally and internationally.

Conference Format

    The Conference will consist of public testimony followed by 
scientific panels and six concurrent workshops. Specifically, on March 
4, individuals representing the full spectrum of organizations 
interested in biomedical and behavioral research on women's health 
issues will have an opportunity to provide public testimony from 2-6 
p.m. On March 5, the intersection of health care, public policy, and 
biomedical research will be addressed in a keynote speech designed to 
stimulate discussion by subsequent panels. The panels will focus on 
emerging issues and trends in health care that will be facing the 
Nation and on research paradigms of the future. The six concurrent 
afternoon sessions will focus on a range of research areas, including 
metagenomics/microbiome, chronic pain, urogenital disorders, the brain 
and neuropsychiatric disorders, urogenital infection, and obesity and 
eating disorders. On March 6, the morning session will be devoted to 
reports from the workshop co-chairs on the deliberations of the 
workshops.
    Throughout the sessions, conference attendees will be encouraged to 
assist the ORWH and NIH in shaping the future of women's health 
research and, by extension, informing health care policy. The 
conference will adjourn at 1 p.m. on March 6.

Public Testimony

    The ORWH invites individuals representing organizations with an 
interest in research areas related to women's health to provide written 
and oral testimony on these topics and/or on issues related to women in 
biomedical careers. Due to time constraints, only one representative 
from an organization or professional specialty group will present oral 
testimony, with presentations limited to 5-7 minutes. Similarly, 
individuals not representing an organized entity but a personal point 
of view will have the same time constraint. A letter of intent to 
present such testimony should be sent electronically to https://
www.orwhmeetings.com/newdirections/ or by mail to Ms. Jory Barone, 
Educational Services, Inc., 4350 East-West Highway, Suite 1100, 
Bethesda, MD 20814, joryb@esi-dc.com. The date of receipt of the 
communication will establish the order of presentations at the March 
meeting.
    Testimony should include a brief description of the organization; 
is limited to no more than 10 pages, double spaced, 12 point font size; 
and should be forwarded to the Web site listed above no later than 
February 20, 2009.
    Individuals and organizations wishing to provide written statements 
only should send two (2) copies of their statements, electronically or 
by mail, to the above Web site or address by February 20, 2009. All 
written testimony will be made available to the conferees prior to the 
March 4 meeting date. Logistics questions related to the March 
conference should be addressed to Ms. Jory Barone at ESI, while 
program-specific questions should be addressed to Dr. Jennifer Stine 
Elam at Washington University, 314-747-0729, elam@wustl.edu.
    This conference is the first of four regional public hearings and 
scientific

[[Page 6648]]

workshops of similar design to be convened by the ORWH. At the 
conclusion of the regional conferences, the ORWH will hold a meeting at 
the NIH to develop a summation of the deliberations from the regional 
conferences. The resulting report to the ORWH and the NIH will ensure 
that women's health research will incorporate vigorous new ideas and 
approaches in the next decade.

    Dated: February 3, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9-2760 Filed 2-9-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.